Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.

The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lirane Elize Defante Ferreto, Stephanny Guedes, Fernando Braz Pauli, Samyra Soligo Rovani, Franciele Aní Caovilla Follador, Ana Paula Vieira, Renata Himovski Torres, Harnoldo Colares Coelho, Guilherme Welter Wendt
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b406624f647a4f2dbe524ef525d92254
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b406624f647a4f2dbe524ef525d92254
record_format dspace
spelling oai:doaj.org-article:b406624f647a4f2dbe524ef525d922542021-12-02T20:09:05ZSeroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.1932-620310.1371/journal.pone.0255173https://doaj.org/article/b406624f647a4f2dbe524ef525d922542021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0255173https://doaj.org/toc/1932-6203The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of injectable drugs and syringe sharing. Nonetheless, efforts in better understanding the dynamics of both HCV and HIV are scarce in developing countries such as Brazil, which poses a risk not only to the inmates but to the community as well. In this investigation, we sought to determine the seroprevalence and sociodemographic and behavioral risk factors associated with HIV and anti-HCV antibodies among men detained at high-security institutions. This is an epidemiological, proportionally stratified observational study including 1,132 inmates aged 18 to 79 years-old (Mage = 32.58±10.18) from eleven high-security prisons located in the State of Paraná, Brazil. We found that HIV and anti-HCV prevalence were 1.6% (95% CI: 1.0-2.5) and 2.7% (95% CI: 1.0-2.5), respectively. Risk factors associated with HIV included not receiving intimate visits (OR = 8.80, 95% CI: 1.15-66.88), already having another sexually transmitted infection (OR = 3.89, 95% CI: 1.47-10.29), and reporting attendance in HIV preventive campaigns (OR = 4.24, 95% CI: 1.58-11.36). Moreover, anti-HCV seroprevalence was associated with higher age (OR = 4.03, 95% CI: 1.61-10.07), criminal recidivism (OR = 2.58, 95% CI 1.02-6.52), and the use of injectable drugs (OR = 7.32, 95% CI 3.36-15.92). Although prisons might increase the risk for acquiring and transmitting HIV and HCV, the adoption of permanent epidemiological surveillance programs could help reducing the circulation of viruses, involving strategies focusing on screening, treating, and preventing infections to assure proper prisoner health. Moreover, these policies need to take place inside and outside the prison environment to offer continued assistance to former prisoners once they leave the institution.Lirane Elize Defante FerretoStephanny GuedesFernando Braz PauliSamyra Soligo RovaniFranciele Aní Caovilla FolladorAna Paula VieiraRenata Himovski TorresHarnoldo Colares CoelhoGuilherme Welter WendtPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0255173 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lirane Elize Defante Ferreto
Stephanny Guedes
Fernando Braz Pauli
Samyra Soligo Rovani
Franciele Aní Caovilla Follador
Ana Paula Vieira
Renata Himovski Torres
Harnoldo Colares Coelho
Guilherme Welter Wendt
Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
description The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of injectable drugs and syringe sharing. Nonetheless, efforts in better understanding the dynamics of both HCV and HIV are scarce in developing countries such as Brazil, which poses a risk not only to the inmates but to the community as well. In this investigation, we sought to determine the seroprevalence and sociodemographic and behavioral risk factors associated with HIV and anti-HCV antibodies among men detained at high-security institutions. This is an epidemiological, proportionally stratified observational study including 1,132 inmates aged 18 to 79 years-old (Mage = 32.58±10.18) from eleven high-security prisons located in the State of Paraná, Brazil. We found that HIV and anti-HCV prevalence were 1.6% (95% CI: 1.0-2.5) and 2.7% (95% CI: 1.0-2.5), respectively. Risk factors associated with HIV included not receiving intimate visits (OR = 8.80, 95% CI: 1.15-66.88), already having another sexually transmitted infection (OR = 3.89, 95% CI: 1.47-10.29), and reporting attendance in HIV preventive campaigns (OR = 4.24, 95% CI: 1.58-11.36). Moreover, anti-HCV seroprevalence was associated with higher age (OR = 4.03, 95% CI: 1.61-10.07), criminal recidivism (OR = 2.58, 95% CI 1.02-6.52), and the use of injectable drugs (OR = 7.32, 95% CI 3.36-15.92). Although prisons might increase the risk for acquiring and transmitting HIV and HCV, the adoption of permanent epidemiological surveillance programs could help reducing the circulation of viruses, involving strategies focusing on screening, treating, and preventing infections to assure proper prisoner health. Moreover, these policies need to take place inside and outside the prison environment to offer continued assistance to former prisoners once they leave the institution.
format article
author Lirane Elize Defante Ferreto
Stephanny Guedes
Fernando Braz Pauli
Samyra Soligo Rovani
Franciele Aní Caovilla Follador
Ana Paula Vieira
Renata Himovski Torres
Harnoldo Colares Coelho
Guilherme Welter Wendt
author_facet Lirane Elize Defante Ferreto
Stephanny Guedes
Fernando Braz Pauli
Samyra Soligo Rovani
Franciele Aní Caovilla Follador
Ana Paula Vieira
Renata Himovski Torres
Harnoldo Colares Coelho
Guilherme Welter Wendt
author_sort Lirane Elize Defante Ferreto
title Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
title_short Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
title_full Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
title_fullStr Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
title_full_unstemmed Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
title_sort seroprevalence and associated factors of hiv and hepatitis c in brazilian high-security prisons: a state-wide epidemiological study.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/b406624f647a4f2dbe524ef525d92254
work_keys_str_mv AT liraneelizedefanteferreto seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT stephannyguedes seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT fernandobrazpauli seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT samyrasoligorovani seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT francieleanicaovillafollador seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT anapaulavieira seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT renatahimovskitorres seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT harnoldocolarescoelho seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
AT guilhermewelterwendt seroprevalenceandassociatedfactorsofhivandhepatitiscinbrazilianhighsecurityprisonsastatewideepidemiologicalstudy
_version_ 1718375145724182528